SecBot SecBot

ALNY

ALNYLAM PHARMACEUTICALS, INC.
Nasdaq· Pharmaceutical Preparations· CIK 0001178670 Biotech & Drug Discovery
$159.73 −5.31 (−3.22%)
Nov 16 4:00 PM ET · prev $165.04
Market cap
$21.0B
Large cap
Consensus
Buy
76% Buy or better · 38 analysts
Median target
$299.00
+87% · range $180.00–455.00
1 year
−65.3%
from $460.54 · Nov 17
30 days
−31.5%
from $233.29
52-week range
$151.64–473.29
−66% from high · low Nov 10
Avg volume 20D
3.33M
Oct 29 spike 11.80M
Short interest
5.47M
≈4.1% of shares · −16.8%
Days to cover
1.9
at average volume
Insider net
−$2.8M
2 buyers · 5 sellers · since Mar 5
New fund stakes
1
Q3 2026 13F · 8 exits
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read MIXED 10 reports · 90 days
Balance 1 bearish · 1 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 7/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders bought $543.1K at an average $154.74. 5 insiders sold $3.4M.

  • InstitutionsMIXED

    Q3 2026: 56 added (1 new), 50 trimmed or exited. Largest new: Hrt Financial $10.6M.

  • AnalystsBULLISH

    29 of 38 rate it Buy or better. Every target is above the price.

  • Short sellersCOVERING

    Short interest −16.8% to 5.47M shares. 1.9 days to cover, ≈4.1% of shares.

  • TrendDOWNTREND

    26% below its 50-day average. New closing low $151.64 on Nov 10.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
1
new positions
8
exits
$10.6M
in new stakes
FundMoveSharesValue
BAILLIE GIFFORD & CODOUBLED5,492,469$1.4B
JPMORGAN CHASE & COTRIM1,722,185$437.6M
MANUFACTURERS LIFE INSURANCE COMPANY, THEADD1,151,730$284.2M
AMERICAN CENTURY COMPANIES INCTRIM1,010,139$249.2M
FIRST TRUST ADVISORS LPADD554,266$136.8M
Pictet Asset Management Holding SAADD495,168$122.8M
CITIGROUP INCADD327,287$80.8M
Hudson Bay Capital Management LPADD200,000$49.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

38 analysts
Buy 76% rate it Buy or better
Strong Buy9Buy20Hold9Sell0Strong Sell0
12-month targets · 27 analysts

Price is below the lowest target. Median implies +87%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 2, 2026Barclays
MAINTAIN
MAINTAINOverweight
Nov 2, 2026Truist Securities
DOWNGRADE
DOWNGRADEHold
Nov 2, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Oct 30, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 30, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Oct 30, 2026Bernstein
DOWNGRADE
DOWNGRADEMarket Perform

Washington

Corporate Lobbying

54 lobbying filings and 4 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$543.1K
bought · 2 insiders
$3.4M
sold · 5 insiders
+3.2%
vs their $154.74 cost
DateInsiderTypeValue
Nov 10, 2026
Sigal Charles Elliott
Director
Nov 10, 2026
BUY$243.6K
Nov 10, 2026
PYOTT DAVID E I
Director
Nov 10, 2026
EXERCISE$272.1K
Nov 9, 2026
SCHULMAN AMY W
Director
Nov 9, 2026
BUY$299.5K
Oct 2, 2026
SUPRAN BRYAN
EVP, CLO and Secretary
Oct 2, 2026
SELL$398.9K
Sep 19, 2026
Greenstreet Yvonne
Chief Executive Officer
Sep 19, 2026
AWARD107 sh
Jun 1, 2026
PYOTT DAVID E I
Director
Jun 1, 2026
SELL$5.1K
Jun 1, 2026
PYOTT DAVID E I
Director
Jun 1, 2026
SELL$148.9K
Jun 1, 2026
PYOTT DAVID E I
Director
Jun 1, 2026
SELL$351.2K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 0 in posts · 1 in comments
Recent comments
All social signals and their track records

Short side

FINRA· Oct 30, 2026
5,465,979
shares short
-16.8%
vs prior settlement
1.9
days to cover
≈4.1%
of shares outstanding
Trading halts
Oct 29, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Capital Research Global Investors (CRGI) filed an amended Schedule 13G disclosing a 8.2% passive stake in Alnylam…
SC 13G/A · Impact 2/10
Nov 13, 2026 SEC
Capital World Investors filed an amended Schedule 13G disclosing a 10.4% passive stake in Alnylam Pharmaceuticals as…
SC 13G/A · Impact 2/10
Nov 12, 2026 Other
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
Nov 10, 2026 Insider
Sigal Charles Elliott bought 1,600 shares
Director @ $152.25 ($243.6K)
Nov 10, 2026 Insider
PYOTT DAVID E I acquired via exercise 3,780 shares
Director @ $71.99 ($272.1K)
Nov 9, 2026 Insider
SCHULMAN AMY W bought 1,910 shares
Director @ $156.82 ($299.5K)
Sep 30, 2026 Inst.
BAILLIE GIFFORD & CO · DOUBLED
5,492,469 shares ($1.4B)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
7 drugs tracked · Drug pipeline →
Recent
Congressional trades
ALNY trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
DateMemberType AmountDisclosed
Aug 11, 2026 Cory BookerDSenate Spouse account · Alnylam Pharmaceuticals Inc SELL $1K–$15K Sep 9, 2026 +29d

SecBot reports

15 filings · 3 bullish · 2 bearish · 10 neutral
All ALNY filing & press-release reports (15)